Acute Respiratory Failure clinical trials

Explore recruiting acute respiratory failure clinical trials.

Recruiting acute respiratory failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Respiratory Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Non-Invasive Ventilation versus High Flow Oxygenotherapy in Patients at High Risk of Extubation Failure

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)

France, Sweden, Bulgaria, Romania, Greece, Italy +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Apneic oxygenation with high-flow nasal oxygenation after preoxygenation with noninvasive ventilation before intubation in hypoxemic patients in intensive care unit. A multicenter randomized controlled trial.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Weaning protocol for high-flow nasal oxygen therapy in the ICU - Multicenter randomized controlled trial. HiFloWEAN

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

EFRAIM II _ Empirical steroids and/or antifungals in immunocompromised patients with acute respiratory failure from undetermined etiology: a multicenter double-blind randomized controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Immunosuppression regimen reduction in kidney transplantation recipients admitted to the intensive care unit in the setting of septic shock and/or acute respiratory failure: an open multicentric randomized phase IV study

France

Phase II and Phase III (Integrated) EU CTIS Study details

Acute Respiratory Failure trials by city

Acute Respiratory Failure in Toronto Acute Respiratory Failure in Vancouver Acute Respiratory Failure in Montreal Acute Respiratory Failure in Calgary Acute Respiratory Failure in Edmonton Acute Respiratory Failure in Ottawa Acute Respiratory Failure in Winnipeg Acute Respiratory Failure in Quebec City Acute Respiratory Failure in Hamilton Acute Respiratory Failure in Kitchener Acute Respiratory Failure in London Acute Respiratory Failure in Halifax Acute Respiratory Failure in New York Acute Respiratory Failure in Los Angeles Acute Respiratory Failure in Chicago Acute Respiratory Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease